Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Drugs and Therapy Perspectives is Scopus-indexed (Q4, CiteScore 1), WoS ESCI. Published by Adis.
Checked against the index lists dated .
ISSN 1172-0360Verify ISSN ↗1179-1977Verify ISSN ↗
Publisher: Adis
Cost to publish: About US$3,490 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 220 / 278 | 21st | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1993–present, best quartile Q4, CiteScore 1.
Drugs and Therapy Perspectives is Q4 in Pharmacology (medical) (rank 220 of 278), by CiteScore 2025.
Drugs and Therapy Perspectives is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1, which places it in quartile Q4 at the 21st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.204, quartile Q3, with an H-index of 16.
The publisher lists an article processing charge of about US$3,490 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Drugs and Therapy Perspectives is published by Adis. Its print ISSN is 1172-0360 and its online ISSN is 1179-1977.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Drugs and Therapy Perspectives has an h-index of 23 and a 2-year mean of 0.57 citations per paper (OpenAlex). Its Scopus CiteScore is 1, quartile Q4. On 2-year citations it ranks #220 of 271 Scopus journals in Pharmacology (medical).
Drugs and Therapy Perspectives published 86 papers in 2025; its busiest recent year was 2018 with 112. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from New Zealand (67.7%), United States (4.7%) and Canada (3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.